2024 International Congress Archives - Page 100 of 181

Long term evaluation of gluten-free diet in Parkinson´s disease patients

H. Brožová, K. Poláková, T. Gentileová, M. Fialová, M. Kubjatková, J. Rusz, M. Sap, M. Kuzma, H. Pelantová, M. Jandová, D. Funda (Prague, Czech Republic)
Long-read sequencing to identify unrevealed second hit in autosomal recessive Parkinson’s disease

K. Daida, H. Yoshino, K. Billingsley, L. Malik, B. Baker, R. Genner, K. Paquette, M. Ishiguro, M. Funayama, Y. Li, K. Nishioka, C. Blauwendraat, N. Hattori (Bethesda, USA)
Long-term Blood Pressure Measures in Incident Parkinson’s Disease in the Framingham Heart Study.

S. O'Shea, Y. Liu, Y. Li, A. Gurnani, J. Dookhy, S. Frank, R. Au, J. Mez, T. Ang, L. Shih (New York, USA)
Long-term effects of Deep Brain Stimulation on gait and postural control in Parkinson’s disease

S. Zheng, JL. Wu, SQ. Liang, Y. Yu, JC. Wu, HT. Li, YY. Cheng (tianjin, China)
Long-Term Efficacy of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) for Motor Fluctuations in Parkinson’s Disease

A. Espay, R. Pahwa, A. Ellenbogen, F. Stocchi, N. Giladi, L. Salin, N. Sasson, J. Pereira, O. Rascol (Cincinnati, USA)
Long-term evaluation of advanced Parkinson’s disease burden and clinical outcomes: results from the PROSPECT observational study

A. Espay, H. Watanabe, A. Lehn, F. Ory-Magne, T. Mestre, D. Safarpour, L. Bergmann, P. Kukreja, K. Onuk, P. Alonso (Cincinnati, USA)
Long-Term Evolution of Advanced Parkinson’s Disease Burden: Subgroup Analysis from the 24 Month International PROSPECT Observational Study

O. de Fabregues, D. Falconer, S. Heshmat, D. Houghton, D. Maltete, Y. Mukai, M. Rollins, L. Bergmann, P. Kukreja, K. Onuk, J. Sarna (Barcelona, Spain)
Long-term follow up of unilateral deep brain stimulation for Parkinson’s disease

F. Sarmento, A. Daga, A. Wang, T. de Araujo, S. Aghili-Mehrizi, J. K. Wong (Gainesville, USA)
Long-term Physical Exercise on Bone Mineral Density, Balance and Gait in Older Adults with Mild to Moderate Parkinson’s Disease

L. Leandro, T. Zotz, O. Matos, M. Olandoski, C. Moreira (Pinhais, Brazil)
Long-term Safety and Efficacy for Motor Fluctuations and Quality of Life With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease: Interim Results From an Ongoing Open Label Extension

F. Bergquist, J. Aldred, C. Carroll, E. Danielsen, M. Facheris, R. Gupta, A. Jeong, A. Spiegel, V. Fung (Mölndal, Sweden)